Investors reacted positively on Monday, leading to a market surge of nearly 900 points, on the heels of promising results from Moderna’s vaccine trial. The biotech company announced that the potential vaccine produced antibodies in some participants, and a larger trial will begin in July.
Image via Unsplash/Fusion Medical Animation